Market revenue in 2021 | USD 0.5 million |
Market revenue in 2030 | USD 0.8 million |
Growth rate | 5% (CAGR from 2021 to 2030) |
Largest segment | Quadrivalent |
Fastest growing segment | Quadrivalent |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bivalent, Quadrivalent |
Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 80% in 2021. Horizon Databook has segmented the Peru meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
Development in healthcare infrastructure and high adoption of international healthcare policies to improve health services in the country will drive market growth. Moreover, increasing incidence of meningococcal disease in the country is anticipated to boost the adoption of vaccination against the disease.
Incidence of IMD in the country is less than 0.1 cases per 100,000 population. Meningococcal vaccine in not included in the National Immunization Program. However, it is recommended for individuals those are at high risk of meningococcal infections.
The Integrated Management of Childhood Illness has improved strategies to curb leading cause of mortality among children under the age of 5. Vaccination campaigns was the most effective to reduce mortality among children.
Horizon Databook provides a detailed overview of country-level data and insights on the Peru meningococcal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Peru meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account